| References |
|
|
Abbott KC,
Hypolite I,
Poropatich RK et al.
(2001)
Hospitalizations for fungal infections after renal transplantation in the United States.
Transplant Infectious Disease: an official journal of the Transplantation Society
3(4):
203–211.
|
|
|
Abdel-Naser MB,
Yousef N,
el-Fakar NZ et al.
(2005)
Invasive zygomycosis with a fatal outcome.
Archives of Dermatology
141(10):
1211–1213.
|
|
|
Almaslamani M,
Taj-Aldeen SJ,
Garcia-Hermoso D et al.
(2009)
An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections.
Medical Mycology: official publication of the International Society for Human and Animal Mycology
47(5):
532–538.
|
|
|
Almyroudis NG,
Sutton DA,
Linden P et al.
(2006)
Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature.
American Journal of Transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
6(10):
2365–2374.
|
|
|
Amran F,
Aziz MN,
Norhalim MIHA et al.
(2011)
In vitro antifungal susceptibilities of Candida isolated from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
Journal of Medical Microbiology [Epub ahead of print].
|
|
|
Balajee SA,
Gribskov JL,
Hanley E,
Nickle D and
Marr KA
(2005)
Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus.
Eukaryotic Cell
4(3):
625–632.
|
|
|
Balajee SA,
Nickle D,
Varga J and
Marr KA
(2006)
Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping.
Eukaryotic Cell
5(10):
1705–1712.
|
|
|
Balajee SA,
Lindsley MD,
Iqbal N et al.
(2007)
Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods.
Journal of Clinical Microbiology
45(8):
2701–2703.
|
|
|
Barker KS and
Rogers PD
(2006)
Recent insights into the mechanisms of antifungal resistance.
Current Infectious Disease Reports
8(6):
449–456.
|
|
|
Busca A,
Marmont F,
Locatelli F et al.
(2010)
Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy.
Mycoses
53(3):
275–278.
|
|
|
Casadevall A and
Pirofski LA
(2003)
The damage–response framework of microbial pathogenesis.
Nature Reviews. Microbiology
1(1):
17–24.
|
|
|
Cassone A
(2008)
Fungal vaccines: real progress from real challenges.
Lancet Infectious Diseases
8(2):
114–124.
|
|
|
Chen SC,
Slavin MA and
Sorrell TC
(2011)
Echinocandin antifungal drugs in fungal infections: a comparison.
Drugs
71(1):
11–41.
|
|
|
Cornely OA,
Maertens J,
Winston DJ et al.
(2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
New England Journal of Medicine
356(4):
348–359.
|
|
|
Datta K,
Bartlett KH,
Baer R et al.
(2009)
Spread of Cryptococcus gattii into Pacific Northwest region of the United States.
Emerging Infectious Diseases
15(8):
1185–1191.
|
|
|
Denning DW
(2003)
Echinocandin antifungal drugs.
Lancet
362(9390):
1142–1151.
|
|
|
Denning DW,
Park S,
Lass-Florl C et al.
(2011)
High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from Lungs of patients with chronic fungal disease.
Clinical Infectious Diseases: An official publication of the Infectious Diseases Society of America
52(9):
1123–1129.
|
|
|
Dismukes WE
(2000)
Introduction to antifungal drugs.
Clinical Infectious Diseases
30(4):
653–657.
|
|
|
Fortun J,
Martin-Davila P,
Sanchez MA et al.
(2003)
Voriconazole in the treatment of invasive mold infections in transplant recipients.
European Journal of Clinical Microbiology & Infectious Diseases
22(7):
408–413.
|
|
|
Galgiani JN,
Ampel NM,
Blair JE et al.
(2005)
Coccidioidomycosis.
Clinical Infectious Diseases: An official publication of the Infectious Diseases Society of America
41(9):
1217–1223.
|
|
|
Garcia-Solache MA and
Casadevall A
(2010)
Global warming will bring new fungal diseases for mammals.
MBio
1(1):
e00061–10.
|
|
|
Hayden RT,
Isotalo PA,
Parrett T et al.
(2003)
In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section.
Diagnostic Molecular Pathology: the American journal of surgical pathology, Part B
12(1):
21–26.
|
|
|
Jain N,
Wickes BL,
Keller SM et al.
(2005)
Molecular epidemiology of clinical Cryptococcus neoformans strains from India.
Journal of Clinical Microbiology
43(11):
5733–5742.
|
|
|
Kauffman CA
(2005)
Candiduria.
Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America
41(suppl. 6):
S371–S376.
|
|
|
Kidd SE,
Hagen F,
Tscharke RL et al.
(2004)
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada).
Proceedings of the National Academy of Sciences of the USA
101(49):
17258–17263.
|
|
|
Landlinger C,
Preuner S,
Willinger B et al.
(2009)
Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology.
Journal of Clinical Microbiology
47(4):
1063–1073.
|
|
|
Luong ML,
Clancy CJ,
Vadnerkar A et al.
(2011)
Comparison of an aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients.
Clinical Infectious Diseases: an publication of the Infectious Diseases Society of America
52(10):
1218–1226.
|
|
|
book
McGinnis MR
(1991)
"Introduction to mycology". In:
Baron S (ed.)
Medical Microbiology, pp.
921–933.
New York: Churchill livingstone Inc.
|
|
|
Moran GP,
Coleman DC and
Sullivan DJ
(2011)
Comparative genomics and the evolution of pathogenicity in human pathogenic fungi.
Eukaryotic Cell
10(1):
34–42.
|
|
|
Mortensen KL,
Jensen RH,
Johansen HK et al.
(2011)
Aspergillus species and other moulds in respiratory samples from cystic fibrosis patients: a laboratory-based study with focus on azole resistance in Aspergillus fumigatus.
Journal of Clinical Microbiology
49(5):
2243–2251.
|
|
|
Pappas PG,
Kauffman CA,
Andes D et al.
(2009)
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America
48(5):
503–535.
|
|
|
Park BJ,
Wannemuehler KA,
Marston BJ et al.
(2009)
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
AIDS
23(4):
525–530.
|
|
|
Perfect JR,
Dismukes WE,
Dromer F et al.
(2010)
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America.
Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America
50(3):
291–322.
|
|
|
Pfaller MA and
Diekema DJ
(2007)
Epidemiology of invasive candidiasis: a persistent public health problem.
Clinical Microbiology Reviews
20(1):
133–163.
|
|
|
Pfaller MA,
Moet GJ,
Messer SA,
Jones RN and
Castanheira M
(2011)
Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008–2009.
Antimicrobial Agents and Chemotherapy
55(2):
561–566.
|
|
|
Pound MW,
Townsend ML,
Dimondi V,
Wilson D and
Drew RH et al.
(2011)
Overview of treatment options for invasive fungal infections.
Medical Mycology: official publication of the International Society for Human and Animal Mycology
49(6):
561–580.
|
|
|
Rogers TR
(2008)
Treatment of zygomycosis: current and new options.
The Journal of Antimicrobial Chemotherapy
61(suppl. 1):
i35–i40.
|
|
|
Schwartz S,
Reisman A and
Troke PF
(2011)
The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.
Infection
39(3):
201–210.
|
|
|
Serrano R,
Gusmao L,
Amorim A and
Araujo R
(2011)
Rapid identification of Aspergillus fumigatus within the section Fumigati.
BMC Microbiology
11(1):
82.
|
|
|
Snelders E,
Melchers WJ and
Verweij PE
(2011)
Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Future Microbiology
6:
335–347.
|
|
|
Tintelnot K,
Lemmer K,
Losert H,
Schar G and
Polak A
(2004)
Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates.
Mycoses
47(11–12):
455–464.
|
|
|
Tsang CA,
Anderson SM,
Imholte SB et al.
(2010)
Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007–2008.
Emerging Infectious Diseases
16(11):
1738–1744.
|
|
|
Vucicevic D,
Blair JE,
Binnicker MJ et al.
(2010)
The utility of Coccidioides polymerase chain reaction testing in the clinical setting.
Mycopathologia
170(5):
345–351.
|
|
|
Wald A,
Leisenring W,
van Burik JA and
RA Bowden
(1997)
Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation.
The Journal of Infectious Diseases
175(6):
1459–1466.
|
|
|
Walsh TJ and
Chanock SJ
(1998)
Diagnosis of invasive fungal infections: advances in nonculture systems.
Current Clinical Topics in Infectious Diseases
18:
101–153.
|
|
|
Walsh TJ,
Anaissie EJ,
Denning DW et al.
(2008)
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clinical Infectious Diseases: An official publication of the Infectious Diseases Society of America
46(3):
327–360.
|
|
|
Wheat LJ,
Freifeld AG,
Kleiman MB et al.
(2007)
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.
Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America
45(7):
807–825.
|
|
|
Williams PL
(2007)
Coccidioidal meningitis.
Annals of the New York Academy of Sciences
1111:
377–384.
|
|
|
Xess I,
Mohanty S,
Jain N and
Banerjee U
(2004)
Prevalence of Aspergillus species in clinical samples isolated in an Indian tertiary care hospital.
Indian Journal of Medical Sciences
58(12):
513–519.
|
| Further Reading |
|
|
book
Casadevall A and
Perfect JR
(1998)
Cryptococcus neoformans.
Washington, DC: ASM Press.
|
|
|
book
Heitman J,
kozel TR,
Kwon-chung KJ,
Perfect JR and
Casadevall A
(2011)
Cryptococcus; From Human Pathogen to Model Yeast.
Washington, DC: ASM Press.
|
|
|
book
Kwon-Chung KJ and
Bennett JE
(1992)
Medical Mycology.
Philadelphia, PA: Lea & Febiger.
|
|
|
book
Mandell GL,
Bennett JE and
Dolin R
(1995)
"Section G mycoses". In:
Terry D (ed.)
Principles and Practice of Infectious Diseases,
4th edn, chap. 236–249, section G, pp.
2288–2393.
New York: Churchill Livingstone.
|
